EP1539099A4 - Phases cristallines liquides inversees comprenant des agents hydrophobes paraffiniques - Google Patents

Phases cristallines liquides inversees comprenant des agents hydrophobes paraffiniques

Info

Publication number
EP1539099A4
EP1539099A4 EP03760279A EP03760279A EP1539099A4 EP 1539099 A4 EP1539099 A4 EP 1539099A4 EP 03760279 A EP03760279 A EP 03760279A EP 03760279 A EP03760279 A EP 03760279A EP 1539099 A4 EP1539099 A4 EP 1539099A4
Authority
EP
European Patent Office
Prior art keywords
hydrophobes
paraffin
liquid crystalline
crystalline phases
reversed liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03760279A
Other languages
German (de)
English (en)
Other versions
EP1539099A2 (fr
Inventor
David M Anderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LYOTROPIC THERAPEUTICS LLC
Original Assignee
LYOTROPIC THERAPEUTICS LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LYOTROPIC THERAPEUTICS LLC filed Critical LYOTROPIC THERAPEUTICS LLC
Publication of EP1539099A2 publication Critical patent/EP1539099A2/fr
Publication of EP1539099A4 publication Critical patent/EP1539099A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP03760279A 2002-06-13 2003-06-13 Phases cristallines liquides inversees comprenant des agents hydrophobes paraffiniques Withdrawn EP1539099A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38790902P 2002-06-13 2002-06-13
US387909P 2002-06-13
PCT/US2003/018457 WO2003106382A2 (fr) 2002-06-13 2003-06-13 Phases cristallines liquides inversees comprenant des agents hydrophobes paraffiniques

Publications (2)

Publication Number Publication Date
EP1539099A2 EP1539099A2 (fr) 2005-06-15
EP1539099A4 true EP1539099A4 (fr) 2009-03-18

Family

ID=29736379

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03760279A Withdrawn EP1539099A4 (fr) 2002-06-13 2003-06-13 Phases cristallines liquides inversees comprenant des agents hydrophobes paraffiniques

Country Status (5)

Country Link
EP (1) EP1539099A4 (fr)
JP (1) JP2005532366A (fr)
AU (1) AU2003243509B2 (fr)
CA (1) CA2488701A1 (fr)
WO (1) WO2003106382A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170079962A1 (en) * 2009-11-11 2017-03-23 Rapamycin Holdings, Llc Oral Rapamycin Preparation and Use for Stomatitus
CN108548931A (zh) * 2018-05-09 2018-09-18 南京岚煜生物科技有限公司 基于微流控芯片检测游离甲状腺素fT4试剂盒及制备和检测方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002043696A1 (fr) * 2000-11-29 2002-06-06 Lyotropic Therapeutics, Inc. Systemes de solvants pour agents pharmaceutiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008537A1 (fr) * 1989-02-06 1990-08-09 Abbott Laboratories Compositions pharmaceutiques administrees oralement
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
US6090800A (en) * 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
EP0975331A1 (fr) * 1997-04-17 2000-02-02 Dumex-Alpharma A/S Nouveau systeme bioadhesif d'administration de medicaments base sur des cristaux liquides
DK0942780T3 (da) * 1997-09-09 2003-10-27 Lyotropic Therapeutics Inc Overtrukne partikler, fremgangsmåder til fremstilling deraf og anvendelse deraf

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002043696A1 (fr) * 2000-11-29 2002-06-06 Lyotropic Therapeutics, Inc. Systemes de solvants pour agents pharmaceutiques

Also Published As

Publication number Publication date
WO2003106382A2 (fr) 2003-12-24
AU2003243509A1 (en) 2003-12-31
AU2003243509B2 (en) 2009-08-20
JP2005532366A (ja) 2005-10-27
CA2488701A1 (fr) 2003-12-24
WO2003106382A3 (fr) 2004-07-22
EP1539099A2 (fr) 2005-06-15

Similar Documents

Publication Publication Date Title
GB2378707B (en) Liquid crystalline medium
GB0425331D0 (en) Inverter
PL377477A1 (pl) Materiały na bazie żelatyny jako waciki
AU2003275135A8 (en) Pouch with spout
GB2393090B (en) Page composition
GB2389858B (en) Firelighters
EP1628919A4 (fr) Distillateur solaire perfectionne
DE60305926D1 (de) Flüssigkristalline polymerzusammensetzungen
GB0308118D0 (en) Single crystal scintillators
DE602004016734D1 (de) Flüssigkristalline zusammensetzung
GB0308128D0 (en) Concentrator
EP1623560A4 (fr) Cellule de torsion
AU2003290214A8 (en) Combined rod-disc crystalline systems with nematic properties
AU2003271967A8 (en) Rad51-brc repeat crystals
GB2406254B (en) Page composition
GB0303520D0 (en) Easy to remove radiator
GB0307531D0 (en) Enzyme crystal structure
ZA200602141B (en) Photovoltaic element
GB0316659D0 (en) NOx removal composition
GB0222479D0 (en) Crystal structure
IL164462A0 (en) Liquid cleaning composition
GB0214081D0 (en) Flow line securing support
GB0207777D0 (en) Easy paving
GB0306714D0 (en) Crystal structure
TW558006U (en) Liquid heating structure

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050106

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ANDERSON, DAVID, M.

A4 Supplementary search report drawn up and despatched

Effective date: 20090216

17Q First examination report despatched

Effective date: 20090831

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100311